1. Current and Novel Agents for the Treatment of Cytomegalovirus Retinitis

   • Toks Akerele
   • Susan Lightman

   Section 1: Cytomegalovirus Retiniti 11 December 2012 Pages: 289 - 297

2. Agents in Development for Cytomegalovirus Infection

   • Dene C. Peters
   • Richelle Paterson

   Section 1: Cytomegalovirus Retiniti 11 December 2012 Pages: 299 - 301

3. Adefovir Dipivoxil

   Section 1: Cytomegalovirus Retiniti 11 December 2012 Pages: 303 - 305

4. Benzimidavir

   Section 1: Cytomegalovirus Retiniti 11 December 2012 Pages: 306 - 307

5. Cytomegalovirus Glycoprotein Vaccine (Chiron)

   Section 1: Cytomegalovirus Retiniti 11 December 2012 Pages: 308 - 309

6. Cytomegalovirus Vaccine Live (Pasteur Mérieux Connaught)

   Section 1: Cytomegalovirus Retiniti 11 December 2012 Pages: 310 - 312

7. GEM 132

   Section 1: Cytomegalovirus Retiniti 11 December 2012 Pages: 313 - 314

8. Sevirumab

   Section 1: Cytomegalovirus Retiniti 11 December 2012 Pages: 315 - 317

9. Valganciclovir

   Section 1: Cytomegalovirus Retiniti 11 December 2012 Pages: 318 - 319

10. The Emerging Role of Fusion Inhibitors in HIV Infection

    • Erik De Clercq

    Section 2: HIV Fusion Inhibitor 11 December 2012 Pages: 321 - 331

11. Fusion Inhibitors in HIV Infection

    • Michelle Wilde
    • Richelle Paterson

    Section 2: HIV Fusion Inhibitor 11 December 2012 Pages: 333 - 335

12. AMD 3100

    Section 2: HIV Fusion Inhibitor 11 December 2012 Pages: 337 - 339

13. Dextrin-2-Sulfate

    Section 2: HIV Fusion Inhibitor 11 December 2012 Pages: 340 - 342

14. FP 21399

    Section 2: HIV Fusion Inhibitor 11 December 2012 Pages: 343 - 344

15. ISIS 5320

    Section 2: HIV Fusion Inhibitor 11 December 2012 Pages: 345 - 346

16. Pentafuside

    Section 2: HIV Fusion Inhibitor 11 December 2012 Pages: 347 - 349

17. PRO 542

    Section 2: HIV Fusion Inhibitor 11 December 2012 Pages: 350 - 351

18. SPC 3

    Section 2: HIV Fusion Inhibitor 11 December 2012 Pages: 352 - 352